Changing the life of patients globally
Reapplix’s first product, the 3C Patch® System is designed to help the suffering of patients with chronic wounds such as hard-to-heal diabetic foot ulcers (DFUs); a condition associated with the co-morbidity of amputations and mortality.
Our technology is continuously supported with high standards of clinical evidence to demonstrate effectiveness in managing non-healing wounds.
Every 20 seconds somewhere in the world someone loses a leg due to the complications of diabetes. At this moment, millions of people with diabetes suffer from poorly healing foot ulcers. These people can be helped when a multidisciplinary foot team shares common goals and follows evidence-based care.”
International Working Group on the Diabetic Foot45
Niels Erik Holm, Reapplix’s co-founder also invented the NovoLet pen, which has helped millions of diabetic patients all over the world since its introduction in the 1980s. Photo: Scanpix